ONCAlert | Upfront Therapy for mRCC
Publications  >  Special Reports  >  2014  >  Breast Cancer (Issue 1)  >  

Advances in the Treatment of HER2-Positive Breast Cancer

William J. Gradishar, MD
Published Online: Dec 17,2014
William J. Gradishar, MD, Betsy Bramsen Professorship of Breast Oncology, Professor in Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, discusses advances in the last year in the treatment of patients with HER2-positive breast cancer.

<<< Back to the Breast Cancer Special Report




Clinical Articles

Advances in the Treatment of HER2-Positive Breast Cancer
Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.